COMPASS PATHWAYS INC. for COMPASS PATHWAYS INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2025 | $140,000 | Replaced |
| 3rd Quarter - Amendment | Jan 20, 2026 | $120,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.
Foreign entity interest: To the extent public policies-whether laws or regulations-have a commercial impact on Compass Pathways, Inc., they would also affect Compass Pathways plc and its subsidiaries.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC RASMUSSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.